LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 57.20
+1.40 (2.51%)
Nov 10, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 4.61 billion as of November 9, 2026. It is the 22,722nd most valuable company in the world and the 1,103rd biggest in Taiwan. Its market cap has increased by 140.84% in one year.
Market Cap
4.61B
Enterprise Value
3.64B
Revenue
473.18M
Global Rank
Country Rank
#1,103 Taiwan
PE Ratio
6.43
ChartMarket Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 4.61B, an increase of 167.71%. That is a compound annual growth rate of 4.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 4.61B | 76.27% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 5.92B |
| Orient Pharma | 5.35B |
| Formosa Laboratories | 5.26B |
| Alar Pharmaceuticals | 4.93B |
| Yoda Pharmaceuticals | 4.84B |
| Panion & Bf Biotech | 4.20B |
| Orient EuroPharma | 3.67B |
| Easywell Biomedicals | 3.09B |